Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
-
-
-
-
-
-
Inovio Pharma (INO) Prices 12.5M Shares at $6
-
-
-
-
-
-
-
Piper Jaffray Cuts PT on Inovio Pharma (INO) to $13 Following FDA Clinical Hold; Affirms at 'Overweight'
-
-
-
-
-
-
-
Inovio Pharmaceuticals (INO) Overweight Rating, $31 PT Reiterated at Piper Jaffray Amid AstraZeneca Deal
-
-
-
-
-
-
-
Inovio Pharma (INO) to Offer Common Shares
-
-
-
-
-
-
-
Inovio Pharma (INO) Closes 21.8M Common Stock Offering
-
-
-
-
-
-
-
Piper Jaffray Starts Inovio Pharmaceuticals (INO) at Overweight
-
-
20,799 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
